Patents by Inventor Lars DITTUS

Lars DITTUS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies to connective tissue growth factor (CTGF) and uses thereof
    Patent number: 12600770
    Abstract: The present disclosure generally relates to anti-CTGF (connective tissue growth factor) antibodies or antigen-binding fragments thereof. Exemplary anti-CTGF antibodies disclosed herein address the need for treatments of conditions modulated by CTGF signaling. In some aspects, the anti-CTGF antibodies or antigen-binding fragments thereof are for diagnostic and/or therapeutic use, for example in a subject in need thereof, such as a human.
    Type: Grant
    Filed: February 27, 2025
    Date of Patent: April 14, 2026
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Andreas-David Brunner, Lars Dittus, Priyanka Gupta, Muriel Lize, Maria Bonatsakis Myzithras, Irina Rybina, Julia Sauer, Wioletta Anna Skronska-Wasek, Heiko Friedrich Stahl
  • ANTIBODIES TO CONNECTIVE TISSUE GROWTH FACTOR (CTGF) AND USES THEREOF
    Publication number: 20250277020
    Abstract: The present disclosure generally relates to anti-CTGF (connective tissue growth factor) antibodies or antigen-binding fragments thereof. Exemplary anti-CTGF antibodies disclosed herein address the need for treatments of conditions modulated by CTGF signaling. In some aspects, the anti-CTGF antibodies or antigen-binding fragments thereof are for diagnostic and/or therapeutic use, for example in a subject in need thereof, such as a human.
    Type: Application
    Filed: February 27, 2025
    Publication date: September 4, 2025
    Inventors: Andreas-David BRUNNER, Lars DITTUS, Priyanka GUPTA, Muriel LIZE, Maria Bonatsakis MYZITHRAS, Irina RYBINA, Julia SAUER, Wioletta Anna SKRONSKA-WASEK, Heiko Friedrich STAHL